The Use of Recombinant Adeno-Associated Virus for Passive Immunization and Protection against Infectious Diseases
-
Published:2024-03
Issue:1
Volume:39
Page:31-39
-
ISSN:0891-4168
-
Container-title:Molecular Genetics, Microbiology and Virology
-
language:en
-
Short-container-title:Mol. Genet. Microbiol. Virol.
Author:
Ryabova E. I.ORCID, Derkaev A. A.ORCID, Pimenov N. V.ORCID, Esmagambetov I. B.ORCID
Reference56 articles.
1. Excler, J.L., Saville, M., Berkley, S., and Kim, J.H., Vaccine development for emerging infectious diseases, Nat. Med., 2021, vol. 27, no. 4, pp. 591–600. https://doi.org/10.1038/s41591-021-01301-0 2. Courtillon, C., Allée, C., Amelot, M., Keita, A., Bougeard, S., Härtle, S., et al., Blood B cell depletion reflects immunosuppression induced by live-attenuated infectious bursal disease vaccines, Front. Vet. Sci., 2022, vol. 9, p. 871549. https://doi.org/10.3389/fvets.2022.871549 3. Malik, J.A., Ahmed, S., Mir, A., Shinde, M., Bender, O., Alshammari, F., et al., The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges, J. Infect. Public Health, 2022, vol. 15, no. 2, pp. 228–240. https://doi.org/10.1016/j.jiph.2021.12.014 4. Travieso, T., Li, J., Mahesh, S., Mello, J.D.F.R.E., and Blasi, M., The use of viral vectors in vaccine development, npj
Vaccines, 2022, vol. 7, no. 1, p. 75. https://doi.org/10.1038/s41541-022-00503-y 5. Teijaro, J.R. and Farber, D.L., COVID-19 vaccines: modes of immune activation and future challenges, Nat. Rev. Immunol., 2021, vol. 21, no. 4, pp. 195–197. https://doi.org/10.1038/s41577-021-00526-x
|
|